Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR-RO

被引:199
作者
Dolar, Davor [1 ,2 ]
Gros, Meritxell [2 ]
Rodriguez-Mozaz, Sara [2 ]
Moreno, Jordi [3 ]
Comas, Joaquim [3 ]
Rodriguez-Roda, Ignasi [2 ,3 ]
Barcelo, Damia [2 ,4 ]
机构
[1] Fac Chem Engn & Technol, Dept Phys Chem, HR-10000 Zagreb, Croatia
[2] Univ Girona, Catalan Inst Water Res ICRA, E-17003 Girona, Spain
[3] Univ Girona, Lab Chem & Environm Engn LEQUiA, E-17071 Girona, Spain
[4] IDAEA CSIC, Dept Environm Chem, Barcelona 08034, Spain
关键词
Emerging contaminants; Pharmaceutical; Membrane bioreactor; Reverse osmosis; Removal from municipal wastewater; ENDOCRINE DISRUPTING COMPOUNDS; SOLID-PHASE EXTRACTION; PERSONAL CARE PRODUCTS; TREATMENT PLANTS; MASS-SPECTROMETRY; AQUATIC ENVIRONMENT; REVERSE-OSMOSIS; RIVER WATER; PHARMACEUTICALS; ANTIBIOTICS;
D O I
10.1016/j.jhazmat.2012.03.029
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The presence of emerging contaminants in the aquatic environment and their potential effects on living organisms has become an issue of growing concern. Among emerging contaminants, pharmaceuticals may enter the aquatic environment due to their high consumption and their incomplete removal in conventional municipal wastewater treatment plants (WWTPs). The main goal of this study was the assessment of the removal efficiency of pharmaceuticals found in municipal wastewater of a coastal WWTP (Castell-Platja d'Aro, Spain) using an integrated pilot scale membrane system (MBR-RO). Twenty multiple-class pharmaceuticals (including psychiatric drugs, macrolide antibiotics, beta-blockers, sulfonamide and fluoroquinolone antibiotics, histamine H-2 receptor antagonists, anti-inflammatories, nitroimidazole, beta-agonist and antiplatelet agent) were measured in real influent with the lowest average concentration for psychiatric drugs (0.017 mu g L-1) to the highest for macrolide antibiotics (2.02 mu g L-1). Although some contaminants were in relatively high concentrations (even up to 2.90 mu g L-1 in the case of ofloxacin). The combination of MBR and RO treatment showed excellent overall removal of target emerging contaminants with removal rates above 99% for all of them. For some compounds (metronidazole, hydrocodone, codein, ranitidine) MBR provided high removal efficiency (up to 95%). Additionally RO membrane showed removal rates always higher than 99%. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:64 / 69
页数:6
相关论文
共 31 条
[21]   Fate of pharmaceuticals and personal care products in wastewater treatment plants - Conception of a database and first results [J].
Miege, C. ;
Choubert, J. M. ;
Ribeiro, L. ;
Eusebe, M. ;
Coquery, M. .
ENVIRONMENTAL POLLUTION, 2009, 157 (05) :1721-1726
[22]   Biological nutrient removal in an MBR treating municipal wastewater with special focus on biological phosphorus removal [J].
Monclus, Hector ;
Sipma, Jan ;
Ferrero, Giuliana ;
Rodriguez-Roda, Ignasi ;
Comas, Joaquim .
BIORESOURCE TECHNOLOGY, 2010, 101 (11) :3984-3991
[23]   Wastewater treatment plants (WWTPs) as a source of sediment contamination by toxic organic pollutants and fecal sterols in a semi-enclosed bay in Korea [J].
Moon, Hyo-Bang ;
Yoon, Sang-Pil ;
Jung, Rae-Hong ;
Choi, Minkyu .
CHEMOSPHERE, 2008, 73 (06) :880-889
[24]   Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment [J].
Radjenovic, J. ;
Petrovic, M. ;
Ventura, F. ;
Barcelo, D. .
WATER RESEARCH, 2008, 42 (14) :3601-3610
[25]   Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment [J].
Radjenovic, Jelena ;
Petrovic, Mira ;
Barcelo, Damia .
WATER RESEARCH, 2009, 43 (03) :831-841
[26]   Occurrences of endocrine disrupting compounds and pharmaceuticals in the aquatic environment and their removal from drinking water: Challenges in the context of the developing world [J].
Rahman, M. F. ;
Yanful, E. K. ;
Jasim, S. Y. .
DESALINATION, 2009, 248 (1-3) :578-585
[27]   The use of RO to remove emerging micropollutants following CAS/UF or MBR treatment of municipal wastewater [J].
Sahar, Eyal ;
David, Inbal ;
Gelman, Yelena ;
Chikurel, Haim ;
Aharoni, Avi ;
Messalem, Rami ;
Brenner, Asher .
DESALINATION, 2011, 273 (01) :142-147
[28]   Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry [J].
Snyder, SA ;
Westerhoff, P ;
Yoon, Y ;
Sedlak, DL .
ENVIRONMENTAL ENGINEERING SCIENCE, 2003, 20 (05) :449-469
[29]   Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals [J].
Snyder, Shane A. ;
Adham, Samer ;
Redding, Adam M. ;
Cannon, Fred S. ;
DeCarolis, James ;
Oppenheimer, Joan ;
Wert, Eric C. ;
Yoon, Yeomin .
DESALINATION, 2007, 202 (1-3) :156-181
[30]   A pilot study for wastewater reclamation and reuse with MBR/RO and MF/RO systems [J].
Tam, L. S. ;
Tang, T. W. ;
Lau, G. N. ;
Sharma, K. R. ;
Chen, G. H. .
DESALINATION, 2007, 202 (1-3) :106-113